SFB-F44 - cell signaling in chronic CNS disorders

• Home SFB-F44
• Teams & Projects 1st Funding Period
• Teams & Projects 2nd Funding Period
• SFB Publications
• Events
• Seminars
• Lunch Discussion Meetings
• Network Cooperations
• Associated Members
• Public Information
• Press Reports
• Open Positions
• Contact and Location

Other relevant publications of Nadia Stefanova

2011 | 2010 | 2009 | 2008 | 2007 | 2005

2011

Stemberger S, Jamnig A, Stefanova N, Lepperdinger G, Reindl M, Wenning GK. (2011)
Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection.
PLoS One. 2011;6(5):e19808. Epub 2011 May 18.

Fellner L, Jellinger KA, Wenning GK, Stefanova N.(2011)
Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts.
Acta Neuropathol. 2011 Jun;121(6):675-93. Epub 2011 May 12.

Köllensperger M, Krismer F, Pallua A, Stefanova N, Poewe W, Wenning GK. (2010)
Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy.
Mov Disord. 2011 Jan 6.

2010

Stemberger S, Poewe W, Wenning GK, Stefanova N. (2010)
Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA -like progressive autonomic failure.
Exp Neurol. 2010 May 21.

Schunk E, Aigner C, Stefanova N, Wenning GK, Herzog H, Schwarzer C. (2010)
Kappa opioid receptor activation blocks progressive neurodegeneration after kainic acid injection.
Published Online: Jun 1 2010

2009

Stefanova N, Bücke P, Duerr S, Wenning GK. (2009)
Multiple system atrophy: an update.
Lancet Neurol, 2009, 8(12):1172-8.

Wenning GK, Stefanova N. (2009)
Recent development in multiple system atrophy.
J Neurol. 2009 Nov;256(11):1791-808. Epub 2009 May 27.

Stefanova N, Hainzer M, Stemberger S, Couillard-Després S, Aigner L, Poewe W, Wenning GK. (2009)
Striatal transplantation for multiple system atrophy--are grafts affected by alpha-synucleinopathy?
Exp Neurol. 2009 Sep;219(1):368-71.

Ubhi K, Lee PH, Adame A, Inglis C, Mante M, Rockenstein E, Stefanova N, Wenning GK, Masliah E. (2009)
Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy.
J Neurosci Res. 2009 Sep;87(12):2728-39.

Köllensperger M, Stefanova N, Pallua A, Puschban Z, Dechant G, Hainzer M, Reindl M, Poewe W, Nikkhah G, Wenning GK. (2009)
Striatal transplantation in a rodent model of multiple system atrophy: Effects on L-Dopa response.
J Neurosci Res. 2009, 87(7):1679-85.

2008

Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG. (2008)
Multiple system atrophy: a primary oligodendrogliopathy.
Ann Neurol 2008 Sep;64(3):239-46.

Stefanova N, Poewe W, Wenning GK. (2008)
Rasagiline is neuroprotective in a transgenic model of multiple system atrophy.
Exp. Neurol. 2008, 210(2): 421-7

Hutterer M, Knyazev P, Abate A, Reschke M, Maier H, Stefanova N, Knyazeva T, Barbieri V, Reindl M, Muigg A, Kostron H, Stockhammer G, Ullrich A. (2008)
Axl and growth arrest specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.
Clin Cancer Res. 2008 Jan 1;14(1):130-8.

2007

Stefanova N, Reindl M, Neumann M, Kahle PJ, Poewe W, Wenning GK. (2007)
Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: Implications for multiple system atrophy.
Mov Disord. 2007, 22(15):2196-2203.

Stefanova N, Kollensperger M, Hainzer M, Cenci A, Poewe W, Wenning GK. (2007)
High dose levodopa therapy is not toxic in multiple system atrophy: experimental evidence.
Mov Disord. 2007 May 15;22(7):969-73.

Kollensperger M, Stefanova N, Reindl M, Poewe W, Wenning GK. (2007)
Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophy.
Mov Disord. 2007 Feb 15;22(3):353-8.

2005

Stefanova N, Reindl M, Neumann M, Haass C, Poewe W, Kahle PJ, Wenning GK. (2005)
Oxidative Stress in Transgenic Mice with Oligodendroglial {alpha}-Synuclein Overexpression Replicates the Characteristic Neuropathology of Multiple System Atrophy.
Am J Pathol. 2005 Mar;166(3):869-76.

Scherfler C, Scholz SW, Donnemiller E, Decristoforo C, Oberladstatter M, Stefanova N, Diederen E, Virgolini I, Poewe W, Wenning GK. (2005)
Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
Neuroimage. 2005 Feb 1;24(3):822-31.

Puschban Z, Stefanova N, Petersen A, Winkler C, Brundin P, Poewe W, Wenning GK. (2005)
Evidence for dopaminergic re-innervation by embryonic allografts in an optimized rat model of the Parkinsonian variant of multiple system atrophy.
Brain Res Bull. 2005 Dec 15;68(1-2):54-8.

Stefanova N, Tison F, Reindl M, Poewe W, Wenning GK. (2005)
Animal models of multiple system atrophy.
Trends Neurosci. 2005 Sep;28(9):501-6.

Stefanova N, Reindl M, Poewe W, Wenning GK. (2005)
In vitro models of multiple system atrophy.
Mov Disord. 2005 Aug; 20 Suppl 12:S53-6.

Scherfler C, Sather T, Diguet E, Stefanova N, Puschban Z, Tison F, Poewe W, Wenning GK. (2005)
Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy).
J Neural Transm. 2005, 112(8):1025-33.

Mantoan L, Stefanova N, Egger KE, Jellinger KA, Poewe W, Wenning GK. (2005)
Failure of caspase inhibition in the double-lesion rat model of striatonigral degeneration (multiple system atrophy).
Acta Neuropathol (Berl). 2005; 109(2):191-7.